Batu Biologics

Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing

Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therepies in the area of immune modulation. Our products are centered around the idea of creating or breaking immune tolerance. The company is currently in the preclinical stages of drug development for its two flagship products: Immstem and Vallovax. Batu Biologics has filed two provisional patents in the field of cancer immunotherapy and plans to significantly expand its IP